Every 8-K that Procter & Gamble (PG) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow PG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PG filings page.
The Procter & Gamble Company reported fiscal 2026 results showing modest growth in a tougher environment. Organic sales grew 1%, with flat volumes and 1 point of pricing, and 9 of 10 categories plus all 7 regions held or grew organic sales. Core EPS was $6.89, up 1%, while currency-neutral Core EPS was $6.80, in line with the prior year. Adjusted free cash flow productivity reached 100%, supported by operating cash flow of $19,556 million and adjusted free cash flow of $15,835 million.
Fourth quarter trends were softer: organic sales were flat and Core EPS of $1.43 declined 3% year over year, with currency-neutral Core EPS down 5%. For the year, Core gross and operating margins compressed by 40 and 70 basis points, respectively. For fiscal 2027, management guides to 1%–3% organic and net sales growth, 0%–3% Core EPS growth, all-in EPS growth of 1%–5%, adjusted free cash flow productivity of 85%–90%, a Core effective tax rate of about 20%, and plans for more than $10 billion in dividends and approximately $5 billion of share repurchases.
The Procter & Gamble Company announced a planned leadership transition. Executive Chairman Jon R. Moeller will retire as Executive Chairman and as a member of the Board of Directors effective July 31, 2026, and will retire from the company on August 14, 2026, after 38 years of service.
Shailesh G. Jejurikar, currently President, Chief Executive Officer and a director, has been appointed Chairman of the Board effective August 1, 2026, in addition to his existing responsibilities, to serve at the pleasure of the Board. The non-employee directors also reappointed Joseph Jimenez as the Board’s independent Lead Director. A news release dated July 29, 2026 announcing these changes is furnished as an exhibit. Procter & Gamble notes its portfolio of leading consumer brands and operations in approximately 70 countries worldwide.
The Procter & Gamble Company reported results for the fourth quarter and fiscal year ended June 30, 2026 and provided fiscal 2027 guidance. Fiscal 2026 net sales were $87.0 billion, up 3%, with organic sales up 1%. Diluted EPS was $6.62, up 2%, and core EPS was $6.89, up 1%. Operating cash flow reached $19.6 billion and adjusted free cash flow productivity was 100%. The company returned over $15 billion to shareholders, including $10.2 billion in dividends and $5.0 billion in share repurchases.
In the June 2026 quarter, net sales were $21.2 billion, up 2%, while diluted EPS declined 15% to $1.26 and core EPS declined 3% to $1.43, as higher SG&A and lower gross margin pressured profitability. Gross margin for the year fell 100 bps to 50.2% and operating margin fell 160 bps to 22.7%. For fiscal 2027, P&G guides all-in and organic sales growth of 1%–3% and diluted EPS growth of 1%–5%, with core EPS expected between $6.89 and $7.11. The company plans around $10 billion in dividends and approximately $5 billion of share repurchases in fiscal 2027.
The Procter & Gamble Company declared a quarterly dividend of $1.0885 per share on its Common Stock and on the Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is payable on or after August 17, 2026.
Common Stock shareowners of record at the close of business on July 24, 2026 and ESOP Convertible Class A Preferred shareowners of record at the start of business on July 24, 2026 will be eligible. P&G reports it has paid dividends for 136 consecutive years and increased its dividend for 70 consecutive years, underscoring its focus on returning cash to shareowners.
The Procter & Gamble Company reported third-quarter fiscal 2026 results showing modest growth in a tougher environment. Organic sales rose 3%, driven by 2% higher volume and 1% pricing, with all 10 product categories and 7 regions growing organically.
Core earnings per share were $1.59, up 3% from the prior year, while currency-neutral core EPS of $1.54 was flat. Core gross margin was 50.0% and core operating margin 22.2%, both about 1 percentage point below last year, reflecting cost and mix pressures despite productivity savings.
Adjusted free cash flow productivity reached a strong 82%. For full-year fiscal 2026, the company maintained guidance for organic sales growth of 0%–4%, net sales growth of 1%–5%, core EPS growth of 0%–4%, and all-in EPS growth of 1%–6%, alongside plans for about $10 billion in dividends and $5 billion in share repurchases.
Procter & Gamble reported fiscal 2026 third-quarter net sales of $21.2 billion, up 7%, with organic sales up 3% on 2% higher volume and 1% pricing. Diluted EPS rose 6% to $1.63, aided by a gain from dissolving the Glad joint venture, while core EPS increased 3% to $1.59.
Operating cash flow was $4.0 billion and adjusted free cash flow $3.0 billion, for 82% adjusted free cash flow productivity. The company returned $3.2 billion to shareholders through $2.5 billion in dividends and over $600 million of buybacks, and recently extended its dividend growth streak to 70 consecutive years.
P&G maintained fiscal 2026 guidance for all-in sales growth of 1%–5% and organic sales growth of in-line to up 4%, and kept diluted EPS growth guidance at 1%–6% and core EPS growth at in-line to up 4%, but now expects EPS near the lower end of the ranges due to about $0.25 per-share headwinds from commodities, tariffs, interest and taxes. The company still plans around $10 billion in dividends and about $5 billion of share repurchases in fiscal 2026.
The Procter & Gamble Company announced that its Board of Directors declared an increased quarterly dividend of $1.0885 per share on its Common Stock and Series A and B ESOP Convertible Class A Preferred Stock. The dividend is payable on or after May 15, 2026 to shareowners of record on April 24, 2026.
The company stated this dividend is a 3% increase from the prior quarterly dividend. P&G highlighted that it has paid a dividend for 136 consecutive years and has raised its dividend for 70 consecutive years, underscoring a long-standing commitment to returning cash to shareowners who value steady income.
The Procter & Gamble Company filed a current report to share that it issued a press release announcing its second quarter results and held a related conference call. The company is also making available a set of informational slides that were referenced on the call and posted on its website.
This report is furnished under Regulation FD, which is meant to ensure all investors have access to the same information at the same time. The filing also lists the company’s common stock and various outstanding debt securities that are registered for trading on the New York Stock Exchange.
The Procter & Gamble Company filed a current report to furnish its latest quarterly earnings release. The company issued a news release covering results for the quarter ended December 31, 2025, and is providing this report under the “Results of Operations and Financial Condition” item.
The filing identifies Procter & Gamble’s common stock and multiple series of notes listed on the NYSE and attaches the earnings news release as an exhibit. This report serves mainly as a formal SEC submission of the previously issued earnings information.
The Procter & Gamble Company disclosed that its Board of Directors declared a quarterly dividend of $1.0568 per share on its Common Stock and on its Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is payable on or after February 17, 2026 to Common Stock shareholders of record at the close of business on January 23, 2026, and to the ESOP preferred shareholders of record at the start of business on the same date. This filing simply reports the Board’s latest dividend decision under Regulation FD.
The Procter & Gamble Company disclosed that Jennifer Davis, currently Chief Executive Officer - Health Care, has notified the company of her intent to retire. The notice was given on December 9, 2025, and her retirement is expected to be effective June 30, 2026.
Davis is retiring after more than 33 years of service with Procter & Gamble, reflecting a long tenure in senior leadership. The filing does not provide additional details on succession or changes to the company’s broader strategy.
Procter & Gamble closed an underwritten public offering of $258,889,000 aggregate principal amount of Floating Rate Notes due November 4, 2075 under its Form S-3 shelf registration. The company also filed related legal opinions as exhibits.
This transaction adds very long-dated debt to P&G’s capital structure, extending maturities far into the future. The filing lists counsel opinions from the Company and from Fried, Frank, Harris, Shriver & Jacobson LLP, which are incorporated by reference.
Procter & Gamble (PG) closed underwritten public offerings of four tranches of senior notes under its Form S-3 shelf. The company issued €500,000,000 of 2.900% Notes due November 3, 2033 and €500,000,000 of 3.650% Notes due November 3, 2045. It also issued $750,000,000 of 4.100% Notes due November 3, 2032 and $500,000,000 of 4.350% Notes due November 3, 2035.
These multi-currency, multi-maturity offerings expand PG’s debt stack in euros and U.S. dollars, locking in fixed coupons across maturities from 2032 to 2045. Legal opinions for each series are included as exhibits.
The Procter & Gamble Company furnished a Regulation FD update tied to its first-quarter results. On October 24, 2025, the company announced those results, hosted a conference call, and made a slide presentation available to investors. The materials are furnished under Item 7.01.
PG attached Exhibit 99.1, titled “Informational Slides Provided by The Procter & Gamble Company,” and included the Inline XBRL cover page file as Exhibit 104. The slides referenced on the call are also posted on the company’s website.
The Procter & Gamble Company furnished a Form 8-K under Item 2.02 to note it issued a news release regarding earnings for the quarter ended September 30, 2025.
The company attached the news release as Exhibit 99.1. The filing is presented as an informational update about recent operating results and financial condition.
The Procter & Gamble Company reported that shareholders approved the 2025 Stock and Incentive Compensation Plan, which authorizes awards covering up to 175,000,000 shares of common stock. The plan permits grants of stock, RSUs, PSUs, options, and SARs, and also allows use of any shares remaining available under the 2019 plan.
At the October 14, 2025 Annual Meeting, all director nominees were elected. Shareholders ratified the independent auditor, and the advisory Say on Pay vote was approved. A shareholder proposal requesting additional reporting on plastic packaging did not pass.
The Procter & Gamble Company announced its Board declared a quarterly dividend of $1.0568 per share on its Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock. The dividend is payable on or after November 17, 2025, to shareholders of record on October 24, 2025.
The company also reported that, according to preliminary voting results, all fourteen Director nominees were elected at the Annual Meeting of Shareholders.
Alexandra Keith, Chief Executive Officer – Beauty at The Procter & Gamble Company, has announced her intention to retire effective February 20, 2026, after more than 36 years with the company. Upon retirement she will enter the company’s standard Written Separation Agreement, which does not provide any cash severance and allows her to retain the remainder of a special equity award scheduled to vest in August 2026.
Per the report, all other equity awards will be retained or pro-rated as set out in the applicable Award Agreement. The disclosure does not include details about a successor or additional transition arrangements.